verapamil hydrochloride

Generic: verapamil hydrochloride

Labeler: hf acquisition co. llc, dba healthfirst
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name verapamil hydrochloride
Generic Name verapamil hydrochloride
Labeler hf acquisition co. llc, dba healthfirst
Dosage Form INJECTION, SOLUTION
Routes
INTRAVENOUS
Active Ingredients

verapamil hydrochloride 2.5 mg/mL

Manufacturer
HF Acquisition Co. LLC, DBA HealthFirst

Identifiers & Regulatory

Product NDC 51662-1270
Product ID 51662-1270_12004047-3162-77ac-e063-6294a90a77a3
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA075136
Listing Expiration 2026-12-31
Marketing Start 2018-09-01

Pharmacologic Class

Classes
calcium channel antagonists [moa] calcium channel blocker [epc] cytochrome p450 3a inhibitors [moa] cytochrome p450 3a4 inhibitors [moa] p-glycoprotein inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 516621270
Hyphenated Format 51662-1270

Supplemental Identifiers

RxCUI
898316
UNII
V3888OEY5R

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name verapamil hydrochloride (source: ndc)
Generic Name verapamil hydrochloride (source: ndc)
Application Number ANDA075136 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 2.5 mg/mL
source: ndc
Packaging
  • 1 SYRINGE, PLASTIC in 1 CARTON (51662-1270-1) / 4 mL in 1 SYRINGE, PLASTIC
source: ndc

Packages (1)

51662-1270-1 1 SYRINGE, PLASTIC in 1 CARTON (51662-1270-1) / 4 mL in 1 SYRINGE, PLASTIC

Ingredients (1)

verapamil hydrochloride (2.5 mg/mL)

Linked Drug Pages (1)

VERAPAMIL HYDROCHLORIDE ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "12004047-3162-77ac-e063-6294a90a77a3", "openfda": {"unii": ["V3888OEY5R"], "rxcui": ["898316"], "spl_set_id": ["74d94dbf-0567-6c15-e053-2991aa0ac6e4"], "manufacturer_name": ["HF Acquisition Co. LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": "1 SYRINGE, PLASTIC in 1 CARTON (51662-1270-1)  / 4 mL in 1 SYRINGE, PLASTIC", "package_ndc": "51662-1270-1", "marketing_start_date": "20180901"}], "brand_name": "VERAPAMIL HYDROCHLORIDE", "product_id": "51662-1270_12004047-3162-77ac-e063-6294a90a77a3", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "51662-1270", "generic_name": "VERAPAMIL HYDROCHLORIDE", "labeler_name": "HF Acquisition Co. LLC, DBA HealthFirst", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "VERAPAMIL HYDROCHLORIDE", "active_ingredients": [{"name": "VERAPAMIL HYDROCHLORIDE", "strength": "2.5 mg/mL"}], "application_number": "ANDA075136", "marketing_category": "ANDA", "marketing_start_date": "20180901", "listing_expiration_date": "20261231"}